Volume 4.15 | Apr 20

Immunology of Infectious Disease News 4.15 April 20, 2016
Immunology of Infectious Disease News
     In this issue: Publications | Reviews | Science News | Industry News | Policy News | Events | Jobs
Like Us on Facebook  IIDN on Twitter
 
TOP STORY
Positive Phase I Data for Ebola Vaccine Regimen
Scientists announced that data from a Phase I study of a preventive Ebola vaccine regimen. Among the findings, 100% of participants in the study achieved an initial antibody response to Ebola, and this response was sustained eight months following immunization. [Press release from the University of Oxford discussing publication in JAMA: The Journal of the American Medical Association]
Press Release 1 | Press Release 2 | Abstract
Perform automated cell isolation from up to 16 samples at once with RoboSep™-16.
 
PUBLICATIONS (Ranked by impact factor of the journal)
Mycobacterium tuberculosis Induces the miR-33 Locus to Reprogram Autophagy and Host Lipid Metabolism
Researchers found that by inducing the microRNA miR-33 and its passenger strand miR-33, M. tuberculosis inhibited integrated pathways involved in autophagy, lysosomal function and fatty acid oxidation to support bacterial replication. [Nat Immunol] Abstract | Press Release

Constitutive Aryl Hydrocarbon Receptor Signaling Constrains Type I Interferon–Mediated Antiviral Innate Defense
Scientists demonstrated that constitutive aryl hydrocarbon receptor (AHR) signaling negatively regulates the type I interferon (IFN-I) response during infection with various types of virus. Virus-induced IFN-β production was enhanced in AHR-deficient cells and mice and resulted in restricted viral replication. [Nat Immunol] Abstract

RUNX2 Mediates Plasmacytoid Dendritic Cell Egress from the Bone Marrow and Controls Viral Immunity
The authors showed that RUNX2 plays an essential role in promoting plasmacytoid dendritic cells (pDCs) localization and function. RUNX2 is required for the appropriate expression of the integrin-mediated adhesion machinery, as well as for the down-modulation of the chemokine receptor CXCR4, which allows pDC egress into the circulation. [Cell Rep] Full Article | Graphical Abstract

MAIT Cells Reside in the Female Genital Mucosa and Are Biased towards IL-17 and IL-22 Production in Response to Bacterial Stimulation
Investigators found that mucosal-associated invariant T (MAIT) cells and MR1+ antigen-presenting cells were present in the upper and lower female genital tract (FGT), with distinct tissue localization of MAIT cells in endometrium vs. cervix. When stimulated with Escherichia coli, MAIT cells from the FGT displayed a bias towards interleukin (IL)-17 and IL-22 expression, whereas blood MAIT cells produced primarily IFN-γ, TNF, and Granzyme B. [Mucosal Immunol] Full Article

HIV

Rapid Inflammasome Activation following Mucosal SIV Infection of Rhesus Monkeys
Researchers showed that HIV-1 can rapidly disseminate following mucosal SIV infection of rhesus monkeys and trigger components of the inflammasome, both at the site of inoculation and at early sites of distal virus spread. [Cell] Abstract | Graphical Abstract | Press Release

NLRX1 Sequesters STING to Negatively Regulate the Interferon Response, Thereby Facilitating the Replication of HIV-1 and DNA Viruses
Scientists found that NLRX1 depletion results in impaired nuclear import of HIV-1 DNA in human monocytic cells. Additionally, NLRX1 was observed to reduce type-I interferon and cytokines in response to HIV-1 reverse-transcribed DNA. [Cell Host Microbe] Abstract | Graphical Abstract | Press Release

Th17 Cells Are Preferentially Infected Very Early after Vaginal Transmission of SIV in Macaques
Working with the macaque simian immunodeficiency virus (SIV) vaginal challenge model, investigators developed methodology to identify discrete foci of SIV infection 48 hours after vaginal inoculation. Phenotyping infected cells revealed that SIV has a significant bias for infection of CCR6+ CD4+ T cells. [Cell Host Microbe] Abstract | Graphical Abstract | Press Release

Nuclear Envelope Protein SUN2 Promotes Cyclophilin-A-Dependent Steps of HIV Replication
Researchers identified related capsid mutants in HIV-1, HIV-2, and SIVmac that are restricted by cyclophilin A (CypA). They showed that wild-type HIV exploits SUN2 in primary CD4+ T cells as an essential host factor that is required for the positive effects of CypA on reverse transcription and infection. [Cell Rep]
Full Article | Graphical Abstract

Subscribe to our sister publications: Human Immunology News and Immune Regulation News!

Isolate particle-free human CD4+CD127lowCD25+ regulatory T cells (Tregs) in less than one hour. Request a sample today.
 
REVIEWS
The Immunology of Host Defense Peptides: Beyond Antimicrobial Activity
The authors focus on human host defense peptides (HDPs) and explore the diverse immunomodulatory effects of HDPs from a systems biology perspective, which highlights the interconnected nature of the effect (or effects) of HDPs on the host. [Nat Rev Immunol] Abstract

Experimental Models of Hepatitis B and C — New Insights and Progress
Scientists describe the important part that experimental models have played in the study of viral hepatitis and led to monumental advances in our understanding and treatment of these pathogens. Ongoing developments in experimental models are also described. [Nat Rev Gastroenterol Hepatol] Abstract

Visit our reviews page to see a complete list of reviews in the immunology of infectious disease research field.
 
SCIENCE NEWS
Antiviral Therapy Prolongs Survival in Immune Tolerant Hepatitis B Patients
A new study demonstrated that the use of antiviral therapy for patients in the immune tolerant phase of Hepatitis B prolongs overall survival and reduces the risk of the most common form of liver cancer and scarring of the liver. [Press release from the European Association for the Study of the Liver (EASL; EurekAlert!) discussing research presented at The International Liver Congress™ 2016, Barcelona] Press Release

Study Demonstrates Benefits of Existing Treatment for Hepatitis D Patients
New research showed that interferon alpha based therapies are effective in suppressing disease progression in a severe form of chronic viral hepatitis, hepatitis delta. [Press release from the European Association for the Study of the Liver (EASL; EurekAlert!) discussing research presented at The International Liver Congress™ 2016, Barcelona] Press Release

Phase II Data Show Treatment Efficacy in ‘Difficult-to-Cure’ Hepatitis C Patients
A hepatitis C (HCV) drug currently under investigation, ABT-493 and ABT-530, which is an all-oral once-daily antiviral treatment, helped HCV genotype 3 patients with heavily scarred livers and no previous treatment history to achieve a 100% sustained virologic response after receiving the treatment for 12 weeks. [Press release from the European Association for the Study of the Liver (EASL; EurekAlert!) discussing research presented at The International Liver Congress™ 2016, Barcelona] Press Release

From our sponsor: Learn how to isolate cells from whole blood in 25 minutes. Watch the video.
 
INDUSTRY NEWS
REPRIEVE, Largest HIV-Related Cardiovascular Disease Clinical Trial Ever, Enrolls More Than 1,000 Participants
The trial is designed to investigate among people living with HIV whether statin use can prevent a very common comorbidity – cardiovascular disease. To date, the clinical trial has enrolled nearly 1,200 participants living with HIV across approximately 85 trial sites. [Massachusetts General Hospital] Press Release

RedHill Biopharma Announces Positive FDA Meeting on RHB-105 Path to Approval and Planned Confirmatory Phase III Study for H. pylori Infection
RedHill Biopharma Ltd. announced that it has concluded a positive type B meeting with the U.S. Food and Drug Administration (FDA) regarding the path to marketing approval of RHB-105 and the planned confirmatory Phase III study. [RedHill Biopharma Ltd.] Press Release
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW Nordic Life Science Days 2016
September 14-15, 2016
Stockholm, Sweden

Visit our events page to see a complete list of events in the immunology of infectious disease community.
 
JOB OPPORTUNITIES
NEW Research Positions – Infection and Immunity (Columbia University)

Scientist – Bioengineering (STEMCELL Technologies Inc.)

Senior Scientist – Immunology and Cell Separation (STEMCELL Technologies Inc.)

Postdoctoral Researcher – HIV Biology (Johns Hopkins University)

Postdoctoral Position – Hepatitis B Virus Infection (University of Strasbourg)

Postdoctoral Position – Dendritic Cells in Inflammation and Infection (Centre d’Immunologie de Marseille Luminy)

Postdoctoral Fellow – Immunology (Ragon Institute of MGH, MIT and Harvard)

Principal Investigators – Infectious Diseases (CCID)

Administrative Head – Vaccine and Infectious Disease (Fred Hutchinson Cancer Research Center)

Research Technician I – HIV Vaccine Trials (Fred Hutchinson Cancer Research Center)


Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Immunology of Infectious Disease News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Immunology of Infectious Disease News: Archives | Events | Contact Us